Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The B-DIT Feasibility Study is a clinical trial designed to evaluate a new treatment program for adults with personality disorders. This program combines traditional face-to-face therapy with online treatment modules, making it more accessible and potentially more effective than standard therapies. The study will look at how well this blended approach works, how satisfied clients are, and whether it helps improve their symptoms and overall functioning. Participants will go through three phases over about ten months, which includes individual sessions, group therapy, and follow-up sessions to reinforce what they've learned.
To be eligible for the study, participants should be 18 years or older and have mild to moderate personality functioning issues. However, certain conditions, such as severe mental health issues or language barriers, may exclude individuals from participating. Throughout the study, clients can expect to receive both in-person and online support tailored to their needs, and their experiences will help researchers understand the effectiveness of this innovative treatment approach.
Gender
ALL
Eligibility criteria
- Inclusion criteria for treatment referral:
- • 1. 18 years of age or older
- • 2. mild to moderately severe impairments in personality functioning, including both cluster B and cluster C personality problems as well as a mixed presentation within unspecified personality disorder.
- General exclusion criteria for treatment at the Viersprong:
- • 1. insufficient proficiency in the Dutch language
- • 2. no permanent place of residence
- • 3. intellectual disability (IQ \< 80)
- • 4. organic brain disorder
- • 5. autism spectrum disorders
- • 6. schizophrenia or schizophreniform disorder
- • 7. (untreated) eating disorder, extreme obesity, or a BMI \< 17.5
- • 8. (untreated) addiction.
- Additional exclusion criteria for the B-DIT treatment:
- • 1. acute risk of crisis requiring stabilizing/crisis interventions
- • 2. Severe PTSD or the severe range of personality problems (structural: low-level borderline organization).
- • There are no additional inclusion/exclusion criteria for participation in the study, other than those that apply to treatment.
About De Viersprong
De Viersprong is a distinguished clinical trial sponsor dedicated to advancing mental health research and innovative treatment solutions. With a strong focus on evidence-based practices, the organization collaborates with leading researchers and healthcare professionals to design and conduct clinical trials that aim to improve therapeutic outcomes for individuals facing mental health challenges. Committed to ethical standards and patient safety, De Viersprong actively engages with participants and stakeholders to foster a collaborative environment that promotes scientific discovery and enhances the quality of care in the mental health field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halsteren, Noord Brabant, Netherlands
Patients applied
Trial Officials
Maaike L Smits, Dr.
Principal Investigator
De Viersprong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported